Many patients with prolactin secreting pituitary tumors have a decreased bone mineral density. The bone loss is associated with an increase in bone resorption and is secondary to prolactin-induced hypogonadism. Normalization of prolactin increases the BMD but is not associated with its normalization. Despite low BMD hyperprolactinemic subjects do not demonstrate increase in fractures compared with the general population
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...
Hyperprolactinaemia is one of the most common problems in clinical endocrinology. It relates with va...
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...
To ascertain the effects of chronic hyperprolactinemia and testosterone deficiency on skeletal integ...
Osteoporosis in the younger age group is an important cause of morbidity. Prolactinoma is an uncommo...
1. The association between hypogonadism and osteoporosis has been reported. We conducted a study to ...
OBJECTIVE: To evaluate the effect of hyperprolactinaemia and its treatment with dopamine-agonists on...
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a ...
Ao longo dos anos, têm se acumulado evidências acerca da morbidade relativa à hiperprolactinemia, es...
Various hormonal disorders can influence bone metabolism and cause secondary osteoporosis. The conse...
Hypogonadism is the most popular cause of BMD decreasing not only in women, but also in men. There a...
Children and adolescents with growth hormone (GH) deficiency (GHD) have reduced bone turnover and bo...
Pituitary adenoma is the most common cause of hyperprolactinemia, which is a rare endocrine disorder...
A 66-year-old man presented with height loss, back pain due to an L4 vertebral compression deformity...
The appearance of postmenopausal osteoporosis is correlated with the peak bone mass achieved during ...
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...
Hyperprolactinaemia is one of the most common problems in clinical endocrinology. It relates with va...
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...
To ascertain the effects of chronic hyperprolactinemia and testosterone deficiency on skeletal integ...
Osteoporosis in the younger age group is an important cause of morbidity. Prolactinoma is an uncommo...
1. The association between hypogonadism and osteoporosis has been reported. We conducted a study to ...
OBJECTIVE: To evaluate the effect of hyperprolactinaemia and its treatment with dopamine-agonists on...
Pituitary hormones have direct and indirect effects on bone remodeling, and skeletal fragility is a ...
Ao longo dos anos, têm se acumulado evidências acerca da morbidade relativa à hiperprolactinemia, es...
Various hormonal disorders can influence bone metabolism and cause secondary osteoporosis. The conse...
Hypogonadism is the most popular cause of BMD decreasing not only in women, but also in men. There a...
Children and adolescents with growth hormone (GH) deficiency (GHD) have reduced bone turnover and bo...
Pituitary adenoma is the most common cause of hyperprolactinemia, which is a rare endocrine disorder...
A 66-year-old man presented with height loss, back pain due to an L4 vertebral compression deformity...
The appearance of postmenopausal osteoporosis is correlated with the peak bone mass achieved during ...
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...
Hyperprolactinaemia is one of the most common problems in clinical endocrinology. It relates with va...
Hyperprolactinemia is one of the risk factor of decrease in bone mass which has been believed to be ...